Page last updated: 2024-10-29

iohexol and Rhabdomyolysis

iohexol has been researched along with Rhabdomyolysis in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alimohammadi, H1
Abdalvand, A1
Safari, S1
Mazinanian, A1
Canbay, O1
Bal, N1
Akinci, S1
Kanbak, M1
Aypar, U1

Other Studies

2 other studies available for iohexol and Rhabdomyolysis

ArticleYear
Status epilepticus after myelography with iohexol (Omnipaque).
    The American journal of emergency medicine, 2012, Volume: 30, Issue:9

    Topics: Anaphylaxis; Contrast Media; Disseminated Intravascular Coagulation; Fatal Outcome; Heart Arrest; Hu

2012
Rhabdomyolysis after intraoperative myelography.
    Paediatric anaesthesia, 2004, Volume: 14, Issue:6

    Topics: Adolescent; Contrast Media; Female; Humans; Intraoperative Period; Iohexol; Myelography; Myoclonus;

2004